| related words |
| retroactively |
| concludes |
| unallocated |
| lilly |
| detecting |
| seizure |
| essentially |
| isolagen |
| cleared |
| biologic |
| disorder |
| prohibitive |
| xerecept |
| symlin |
| fareston |
| abbreviated |
| inspectra |
| resurfacing |
| materiality |
| dysfunction |
|
| related documents |
| 1275283--2/27/2007--REYNOLDS_AMERICAN_INC |
| 1180145--3/27/2007--REPLIDYNE_INC |
| 1142576--3/11/2010--OPTIMER_PHARMACEUTICALS_INC |
| 1142576--3/26/2008--OPTIMER_PHARMACEUTICALS_INC |
| 1142576--3/12/2009--OPTIMER_PHARMACEUTICALS_INC |
| 1158223--4/2/2007--AFFYMAX_INC |
| 1142576--3/30/2007--OPTIMER_PHARMACEUTICALS_INC |
| 32621--7/14/2010--EMERSON_RADIO_CORP |
| 1158223--3/4/2010--AFFYMAX_INC |
| 1003607--12/28/2009--ALTIGEN_COMMUNICATIONS_INC |
| 32621--7/14/2009--EMERSON_RADIO_CORP |
| 768408--8/16/2007--CYANOTECH_CORP |
| 802257--9/28/2009--BRAIN_TREE_INTERNATIONAL_INC |
| 1158223--3/12/2009--AFFYMAX_INC |
| 1003607--12/29/2008--ALTIGEN_COMMUNICATIONS_INC |
| 1158223--3/13/2008--AFFYMAX_INC |
| 1180145--3/14/2008--REPLIDYNE_INC |
| 32621--7/11/2008--EMERSON_RADIO_CORP |
| 1130950--4/14/2006--EXCELLIGENCE_LEARNING_CORP |
|
| related topics |
| {product, liability, claim} |
| {control, financial, internal} |
| {stock, price, share} |
| {loan, real, estate} |
| {regulation, change, law} |
| {product, market, service} |
| {cost, contract, operation} |
| {regulation, government, change} |
| {operation, natural, condition} |
| {system, service, information} |
| {capital, credit, financial} |
| {stock, price, operating} |
| {interest, director, officer} |
| {condition, economic, financial} |
| {product, candidate, development} |
| {competitive, industry, competition} |
| {operation, international, foreign} |
| {personnel, key, retain} |
| {investment, property, distribution} |
| {acquisition, growth, future} |
|